1. Introduction {#sec1-ijerph-17-04745}
===============

Cardiovascular disease (CVD) is the number one cause of death globally, causing an estimated 17.9 million deaths each year, one-third of which occur prematurely in persons aged 70 years and younger \[[@B1-ijerph-17-04745]\]. The American Heart Association suggests carotid artery ultrasound, a noninvasive imaging test, for the evaluation of cerebrovascular and cardiac disease risks. It images arteriosclerosis that characterizes subclinical CVD burden, including the progressive luminal narrowing of the arteries, arterial stiffening, wall thickening, and plaque formation before a person manifests the clinical symptoms of CVD \[[@B2-ijerph-17-04745]\].

Carotid intima--media thickness (IMT), a noninvasive, B-mode ultrasound-based measure of the carotid artery by ultrasonography, is a well-established and commonly used early surrogate marker of subclinical atherosclerosis \[[@B3-ijerph-17-04745]\]. Carotid IMT predicts CVD incidence or death in the participants of the atherosclerosis risk in communities (ARIC) study recruited from four communities in the United States of America \[[@B4-ijerph-17-04745]\] and in asymptomatic persons with at least three CVD risk factors from five European countries \[[@B5-ijerph-17-04745]\]. Carotid IMT modestly improves the prediction of CVD death or all-cause mortality after considering the traditional risk factors in participants of the Cardiovascular Health Study (CHS) \[[@B6-ijerph-17-04745]\] and in a single-center elderly population community in the Netherlands \[[@B7-ijerph-17-04745]\]. Carotid IMT has also been examined in some special populations, such as persons with type 2 diabetes and chronic kidney disease \[[@B8-ijerph-17-04745]\], those with peripheral artery disease \[[@B9-ijerph-17-04745]\], and HIV-positive persons \[[@B10-ijerph-17-04745]\].

To the best of our knowledge, no studies have examined the incremental value of IMT along with the inflammatory marker of hs-CRP, and a novel cardiovascular risk factor of urinary albumin--creatinine ratio (ACR) in addition to traditional factors of all-cause mortality in the general population. The aim of the current study was to estimate the independent and joint associations of IMT markers and additional predictive ability of IMT markers along with hs-CRP and ACR in the prediction of all-cause mortality in community-dwelling Taiwanese adults.

2. Materials and Methods {#sec2-ijerph-17-04745}
========================

2.1. Study Design and Study Subjects {#sec2dot1-ijerph-17-04745}
------------------------------------

The participants were from the second wave of data in 2007 for Taichung Community Health Study (TCHS) and TCHS for family (TCHS-F), a single-center population-based prospective cohort study including providing extracranial carotid artery ultrasound measurement and a fasting blood sample. A total of 2359 participants (66.83% overall response rate) were selected for TCHS from residents aged 40 years and older in Taichung City, Taiwan in 2004. TCHS-F was a family study. TCHS-F had enlisted 807 families with more than one first-degree relative of TCHS participants. TCHS-F specified the inclusion criteria of adults who were spouses or first-degree blood relatives aged 20 years or older. A total of 1919 family members participated. The third wave of data collection for TCHS and the first wave of data collection for TCHS-F included IMT measurements. In the present prospective cohort study, we specified those who were aged at least 30 years, and 2956 persons were eligible. This study was approved by the Human Research Committee of China Medical University Hospital (CMUH105-REC1-002), all methods were carried out in accordance with relevant guidelines and regulation, and informed consent was obtained from each participant.

2.2. Measurements {#sec2dot2-ijerph-17-04745}
-----------------

We used a physical check-up procedure and a standardized questionnaire to complete data collection for sociodemographic factors, lifestyle behaviors, disease histories, and medication history was collected. We performed anthropometric measurements and collected blood samples. Weight and height were measured using an autoanthropometer (superview, HW--666) with the subjects barefoot and wearing light clothing. Body mass index (was derived by weight (kg) over height squared (m^2^). Blood pressure was measured in a seated position using an electronic device (OMRON, HEM-770A, Kyoto, Japan). Blood was drawn in the morning after a 12-h overnight fast with minimal trauma from an antecubital vein. Biochemical markers were analyzed using a biochemical autoanalyzer (Beckman Coluter, Lx-20, Brea, CA, USA), including fasting plasma glucose, triglyceride, HDL-cholesterol, uric acid, urine albumin, and creatinine at the Clinical Laboratory Department of China Medical University Hospital. Urinary ACR was measured using the morning urine sample as a marker of albumin excretion rate. Hs-CRP level was determined by nephelometry, a latex particle-enhanced immunoassay (TBA-200FR, Tokyo, Japan) with inter-assay and intra-assay CVs of \<2.0% and 1.9%, respectively; the lower detection limit of the assay was 0.1 mg/L.

2.3. Extracranial Carotid Artery Ultrasound Measurement {#sec2dot3-ijerph-17-04745}
-------------------------------------------------------

IMT measurements were conducted following the standardized procedure by GE Vivid7 color Doppler ultrasound diagnostic apparatus (Vivid 7 Pro, GE, Horten, Norway) by two operators. After taking a rest for approximately 10 min in supine position with the neck in slight hyperextension, all study subjects underwent carotid ultrasound examination with a 10.0 MHz probe to scan the far and near walls of arterial segments (common carotids, bifurcations, and internal carotid arteries). This procedure was performed bilaterally to obtain the transverse and longitudinal (posterior oblique, lateral, and anterior oblique) views. A computer recorded each ultrasound image with an online digital filing system and recorded atherosclerotic plaques and intima--media complex thickness. The maximal IMT of each segment was derived from the mean of three frames of the maximum values of near and far walls on both the left and right sides. Carotid IMT was calculated as a composite measure (maximum of eight carotid sites) that combines the near and far walls of the common carotid arteries IMT, bulb IMT, and internal carotid artery IMT of both sides of the neck. To quantify the degree of stenosis, we defined carotid stenosis as diameter stenosis \<25%, 25--36% diameter stenosis, and ≥36% diameter stenosis. The presence or absence of plaque grade was defined as the presence of the intima--media's focal thickening \>1 mm that bulged out into the carotid artery's lumen with at least twice as thickness as the IMT on either side \[[@B11-ijerph-17-04745]\]. The intra-operator reliability of carotid IMT for two operators were 0.85 and 0.97, respectively, and the inter-operator reliability was 0.88.

2.4. Statistical Analysis {#sec2dot4-ijerph-17-04745}
-------------------------

Simple descriptive analyses of proportion were used for categorical variables and mean with standard deviation for continuous variables. The differences in baseline characteristics between mortality status were evaluated using two-sample *t*-tests for continuous variables and Chi-square or Fisher's exact tests for categorical variables. We estimated Kaplan--Meier (K--M) mortality cumulative incidence presented as plots, and log-rank test was used to examine the differences in K--M mortality between subgroups of baseline carotid IMT (\<1.0, 1.0--2.0 and ≥2.0 mm), carotid plaque (no, yes), and carotid stenosis (\<25%, 25--36% and ≥36%). Multivariate Cox proportional hazard models estimated the hazard ratios (HRs) and their 95% confidence intervals (CIs). We tested the assumption of proportionality and the assumption of proportionality was held. The HRs of all-cause mortality stratified by gender were presented, and the interaction terms of IMT markers and gender were examined by likelihood ratio tests with entry of the product terms of each IMT marker and gender into the full models. Restricted cubic splines were applied in Cox models to examine the presence of a dose-response or nonlinear association of IMT markers (carotid IMT and carotid stenosis) as continuous variable with mortality. We explored the joint effect of three IMT markers: carotid plaque, IMT, and carotid stenosis. We estimated the areas under the receiver operating characteristic (AUROC) curves to assess the relative ability of IMT markers in correctly classifying mortality status. The analyses were performed with SAS version 9.4 (SAS, Cary, NC, USA). We considered two-tailed *p*-values, and a *p*-value \< 0.05 indicated statistical significance.

3. Results {#sec3-ijerph-17-04745}
==========

A total of 2956 adults were analyzed. Approximately half of them were male (46.4%). The mean age at baseline of adults who died and were alive were 70.05 years (SD = 11.51 years) and 54.32 years (SD = 11.27 years), respectively. IMT was moderately correlated with carotid plaque and carotid stenosis (point-biserial coefficient *r* = 0.71 and Pearson correlation coefficient *r* = 0.78) and carotid plaque with carotid stenosis (point-biserial correlation coefficient *r* = 0.44). The distributions of baseline characteristics according to mortality status are shown in [Table 1](#ijerph-17-04745-t001){ref-type="table"}.

Cumulative incidence curves of death, which was estimated by the Kaplan--Meier method, within subgroups defined by IMT ([Figure 1](#ijerph-17-04745-f001){ref-type="fig"}A), carotid plaque ([Figure 1](#ijerph-17-04745-f001){ref-type="fig"}B), and carotid stenosis ([Figure 1](#ijerph-17-04745-f001){ref-type="fig"}C) were presented. Persons who had higher IMT, carotid plaque, and carotid stenosis had an increased mortality risk (all *p*-values for log-rank tests \<0.001).

[Table 2](#ijerph-17-04745-t002){ref-type="table"} presents the incidence density rates and HRs of all-cause mortality according to the subgroups of IMT, carotid plaque, and stenosis. After multivariate adjustment, persons at subgroup of ≥2.0 mm IMT were associated with an increased risk of all--cause mortality (HR \[CI\]: 1.79 \[1.07--3.00\]) compared with those with IMT \< 1.0 mm. Compared with adults without carotid plaque, the multivariate-adjusted HR (CI) of all-cause mortality was 1.65 (1.17--2.32) for those who had carotid plaque. The mortality risk for persons whose carotid stenosis was 25--36% was 1.57 times higher than those whose carotid stenosis was \<25%. Multivariable restricted cubic spline plots for all-cause mortality by carotid IMT and carotid stenosis are shown in [Figure 2](#ijerph-17-04745-f002){ref-type="fig"}. The multivariable splines for carotid IMT and carotid stenosis demonstrated nonlinear associations with all-cause mortality. The curve of HRs for IMT appears roughly M shape with two peaks at 2.0 and 3.8 mm and the HR was greatest at 3.8 mm. The HRs for carotid stenosis were close to 1 before 25% and then gradually increased and reached the peak at 30% and then gradually decreased; and there was a turning point at 36% and reached the peak at 43%.

Associations among IMT, carotid plaque, stenosis, and all-cause mortality were stratified by gender ([Figure 3](#ijerph-17-04745-f003){ref-type="fig"}). The HR of mortality for IMT and carotid plaque in men were slightly higher than those in women. In men, HRs (95% CI) for IMT ≥ 2.0 mm were 2.43 (1.12--5.27, *p* for trend 0.01) and 1.83 (1.15--2.90) for carotid plaque. Given the small sample size, interactions between gender and IMT and carotid plaque were not significant. [Figure 4](#ijerph-17-04745-f004){ref-type="fig"} shows the adjusted HRs of all-cause mortality for the joint effects of carotid plaque, IMT, and carotid stenosis. Owing to the limited number of persons with no plaque, IMT \< 2.0 mm but stenosis ≥25% or with plaque, IMT \< 1.0 mm, and stenosis \<25% or ≥25%, we could not estimate their joint effects. We observed significant HRs of all-cause mortality for persons with plaque, IMT 1.0--2.0 mm or ≥2.0 mm, and stenosis ≥25% compared with persons with no plaque, IMT \< 1.0 mm, and carotid stenosis \< 25% (HR = 2.73, 95% CI = 1.24--6.00; and HR = 1.86, 95% CI = 1.09--3.19, respectively).

The AUROC curves ([Figure 5](#ijerph-17-04745-f005){ref-type="fig"}) demonstrated that individual IMT (c-statistic = 0.71) was the only IMT marker with good predictive ability (c-statistic \> 0.70), followed by carotid plaque (0.67) and carotid stenosis (0.65). Among all traditional factors, age had the best predictive ability (c-statistic = 0.83), followed by ACR (0.66) and hs-CRP (0.60). Considering these three IMT markers along with the traditional risk factors (0.85) significantly increased their predictive ability of all-cause mortality compared with any individual variable's predictive ability (all *p*-values \< 0.001).

4. Discussion {#sec4-ijerph-17-04745}
=============

In the present prospective cohort study, we demonstrated that carotid IMT, carotid plaque, and carotid stenosis were all moderately correlated with one another. However, each remained an independent risk factor for all-cause mortality after considering traditional risk factors. In addition, we reported the joint effects of these three IMT markers and found that the magnitude of the strength of joint association was substantially greater than that of individual IMT markers, which will improve the risk stratification for mortality. These three IMT markers along with traditional risk factors resulted in remarkably good ability to predict CVD as measured by the c-statistic.

The quantification of IMT and carotid plaques as measured by ultrasonography is a strong predictor of cardiovascular endpoints in various populations \[[@B4-ijerph-17-04745],[@B5-ijerph-17-04745],[@B6-ijerph-17-04745],[@B7-ijerph-17-04745],[@B8-ijerph-17-04745],[@B10-ijerph-17-04745],[@B12-ijerph-17-04745]\]. These prior studies focused on whether additional prediction ability of IMT and carotid plaques on cardiovascular endpoints may serve as an add-on to traditional risk factors, especially hs-CRP. Albuminuria, an indicator of generalized endothelial dysfunction that speeds up atherosclerosis \[[@B13-ijerph-17-04745]\], is a predictor marker to evaluate the increased risks of CVD \[[@B14-ijerph-17-04745],[@B15-ijerph-17-04745]\] or mortality \[[@B16-ijerph-17-04745],[@B17-ijerph-17-04745]\]. In addition, ACR, a biomarker for measuring albuminuria, is associated with ACR and carotid IMT \[[@B18-ijerph-17-04745],[@B19-ijerph-17-04745]\]. However, previous studies did not consider albuminuria as a covariate on the association between IMT or plaque measurements and cardiovascular outcomes to rule out its confounding effect. Our data indicated that the AUROC value for ACR was significantly higher than that for hs-CRP. Simultaneously considering these three IMT markers along with the traditional risk factors (c-statistic: 0.85) significantly increased their predictive ability of all-cause mortality.

Two studies conducted among persons of general population from the CHS and ARIC studies found significant associations between IMT measurements and CVD incidence and all-cause mortality \[[@B6-ijerph-17-04745]\] or coronary heart disease \[[@B4-ijerph-17-04745]\]. Cao identified an association using carotid IMT measurement, which is a composite measure that merges the maximum internal and common carotid wall thickness of the right and left carotid arteries, and explored the independent effects of carotid IMT and plaque \[[@B6-ijerph-17-04745]\]. Nambi evaluated whether the Framingham CHD risk score had a significant improvement by using IMT measurement, estimated by the mean of the mean measurements across the segments of carotid artery bifurcation, distal common carotid, and proximal internal carotid arteries for both right and the left sides, and/or the presence or absence plaque over the model with Framingham traditional risk factors \[[@B4-ijerph-17-04745]\]. The values of c-statistics, which indicates the discriminatory ability of the models, for all-cause mortality and composite CHD outcomes in the previous studies were 0.7582 and 0.7086, respectively, with consideration of combined carotid IMT and plaque as carotid atherosclerosis along with traditional risk factors. However, in the latter study, the CHD incidence was 0.755. The value of c-statistics in our study was 0.85, which was considerably higher than those in these two studies. Variations in IMT measurements and covariates considered may partially explain why these findings differ from ours. A prior study has shown that vegetable diversity was associated with IMT and 15-year atherosclerotic vascular disease mortality \[[@B20-ijerph-17-04745]\]. Different geographical areas with different dietary behaviors may explain the differences. Our study adopted the maximum values of the maximum measurements of the right and left sides across the distal common carotid, carotid artery bifurcation, and proximal internal segments of carotid arteries. In addition to plaque and IMT measurements, we measured carotid stenosis. Although only IMT marker alone had good predictive ability, these three markers were independently associated with all-cause mortality after considering traditional risk factors. Furthermore, the strength of association for the joint variables of these markers was considerably greater than that for individual markers, indicating these three IMT markers improved risk stratification for mortality.

The non-invasive measurement for extracranial carotid artery and internal carotid artery (ICA, carotid bulb) IMT, and plaques to predict cardiovascular risk is an easy and accessible method for the general population \[[@B21-ijerph-17-04745]\]. The relative risk of stroke is higher in the patients with extracranial internal carotid artery stenosis than the patients with intracranial artery stenosis \[[@B22-ijerph-17-04745]\]. The incidence of stroke by occlusion and artery-to-artery embolism of extracranial internal carotid artery high-grade atherosclerosis is high. The association between intracranial atherosclerotic disease and extracranial atherosclerotic disease has been evaluated in white and Asian patients with previous cardiac diseases or stroke \[[@B23-ijerph-17-04745]\]. Stenosis in extracranial common carotid artery and internal carotid artery was associated with more than two times the odds of having stenosis in the intracranial arteries \[[@B23-ijerph-17-04745]\]. Thus, IMT measurement has been proposed as a measure of subclinical CVD for assessing global cardiovascular risk by two consensus groups \[[@B24-ijerph-17-04745],[@B25-ijerph-17-04745]\].

In the present study we provided evidence that increased IMT thickness, carotid plaque, and carotid stenosis were significant independent predictors of mortality in a Taiwanese general population. It has been reported cardiovascular risk factors of systolic blood pressure, high-density lipoprotein, diabetes, and smoking are associated with the mean common carotid artery IMT \[[@B26-ijerph-17-04745]\]. Lifestyle changes and therapeutic approaches to carotid atherosclerosis underline the potential clinical implications of our study's findings. Many lifestyle changes could slow the progression of carotid artery stenosis such as cessation of smoking and tobacco products use, daily physical exercise, body weight control, reduction in dietary calories intake, and low intake in saturated fats, cholesterol, and sodium \[[@B27-ijerph-17-04745]\]. Therapeutic approaches such as antihypertensive and antihyperlipidemia drugs have been demonstrated to reduce the atherosclerosis development measured by CIMT \[[@B28-ijerph-17-04745]\].

The TCHS study has several strengths. It examined a large number of traditional factors, including hs-CRP and ACR, thereby allowing us to identify the additional predictive ability of IMT for predictive purposes. TCHS was conducted in a community with probability sampling approach. We had standardized approaches for carotid image acquisition. Carotid IMT measurement across operators and all operators were trained and certified. We analyzed all scans blindly in the same reading center. The values for within-operator and between operators were in good agreement. By linking with national death registry resulting in all participants with complete follow-up, "loss to follow-up" bias may have minimally affected our study results. Finally, we considered many potential confounders, such as the inflammatory markers of hs-CRP, WBC, and ACR, in addition to traditional cardiovascular biomarkers in our multivariate analyses.

Our study has some potential limitations. The findings can only be generalized to the general Chinese population. Especially, the HRs we observed were slightly larger than those reported in other Western populations \[[@B6-ijerph-17-04745]\] but smaller than in patients with type 2 diabetes and chronic kidney disease \[[@B8-ijerph-17-04745]\]. Finally, the low number of cardiovascular events have limited us to explore the effects of IMT on CVD-specific mortality.

5. Conclusions {#sec5-ijerph-17-04745}
==============

Carotid IMT, carotid plaque, and carotid stenosis each independently contributed to all-cause mortality. Our study supports evidence of blood pressure-related media thickening markers to assess future mortality risks in Chinese adults of general population. The addition of carotid atherosclerosis measures to conventional risk factors resulted in a modest increase in the ability to predict all-cause mortality on the basis of ROC analysis.
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###### 

The distributions of baseline socio-demographic factors, lifestyle behaviors, disease history, blood biochemical indexes according to mortality status.

  Variables                               Mortality Status n (%)   *p*-Value         
  --------------------------------------- ------------------------ ----------------- ---------
  Socio-demographic factors                                                          
  Men                                     1205 (44.4)              167 (69.01)       \<0.001
  Age (years)                             54.32 ± 11.27            70.05 ± 11.51     \<0.001
  Educational attainment                                                             \<0.001
  ≤6 years                                213 (17.15)              57 (31.32)        
  7--12 years                             527 (42.43)              65 (35.71)        
  ≥13 years                               502 (40.42)              60 (32.97)        
  Married                                 2162 (79.66)             203 (83.88)       0.14
  Body mass index (kg/m^2^)                                                          0.61
  \<18.5                                  73 (2.69)                9 (3.72)          
  18.5--25                                1636 (60.28)             141 (58.26)       
  25--30                                  843 (31.06)              74 (30.58)        
  ≥30                                     162 (5.97)               18 (7.44)         
  Lifestyle behaviors                                                                
  Smoking                                 362 (13.34)              43 (17.77)        0.07
  Alcohol drinking                        483 (17.80)              56 (23.14)        0.05
  Physical activity                       1698 (62.56)             167 (69.01)       0.05
  *Disease history*                                                                  
  Hypertension                            662 (24.39)              130 (53.72)       \<0.001
  Diabetes Mellitus                       245 (9.03)               63 (26.03)        \<0.001
  Heart disease                           277 (10.21)              71 (29.34)        \<0.001
  Stroke                                  37 (1.36)                25 (10.33)        \<0.001
  Cancer                                  82 (3.02)                25 (10.33)        \<0.001
  CKD (eGFR \< 60 mL/min/1.73 m^2^)       117 (4.31)               67 (27.69)        \<0.001
  Blood biochemical indexes †                                                        
  Fasting plasma glucose (mg/dL)          100.85 ± 22.34           111.57 ± 33.99    \<0.001
  Total cholesterol (mg/dL)               199.08 ± 35.28           190.18 ± 36       \<0.001
  Triglyceride (mg/dL)                    121.87 ± 89.75           137.55 ± 95.37    0.01
  High-density lipoprotein (mg/dL)        48.88 ± 14.08            44.47 ± 13.09     \<0.001
  Low-density lipoprotein (mg/dL)         120.94 ± 31.27           112.64 ± 31.81    \<0.001
  WBC (10^3^/mL)                          5.75 ± 1.56              6.12 ± 1.70       \<0.001
  ACR (mg/g)                              21.82 ± 103.34           127.66 ± 532.54   0.002
  Fasting insulin (IU/L)                  6.74 ± 4.79              7.73 ± 8.47       0.08
  Hs-CRP (mg/L)                           0.16 ± 0.28              0.27 ± 0.44       \<0.001
  Measurements of the carotid arteries                                               
  Total carotid intima--media thickness                                              \<0.001
  \<1.0 mm                                857 (31.58)              20 (8.26)         
  1.0--2.0 mm                             1426 (52.54)             107 (44.21)       
  ≥2.0 mm                                 431 (15.88)              115 (47.52)       
  Carotid plaque                                                                     \<0.001
  No                                      1470 (54.16)             47 (19.42)        
  Yes                                     1244 (45.84)             195 (80.58)       
  Carotid stenosis                                                                   \<0.001
  \<25%                                   2385 (87.88)             140 (57.85)       
  25%--36%                                195 (7.18)               51 (21.07)        
  ≥36%                                    134 (4.94)               51 (21.07)        

CKD: chronic kidney disease; †: mean (SD). Student's *t*-test was used for continuous variables to calculate *p*-values. Chi-square test was used for categorical variables to calculate *p*-values.
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###### 

Hazard ratios of all-cause mortality according to intima--media thickness, carotid plaque, and carotid stenosis.

  Variables                 n      Cases   Person-Years   Incidence Rate   Age and Sex-Adjusted       Multivariate-Adjusted ^1^   Multivariate-Adjusted ^2^
  ------------------------- ------ ------- -------------- ---------------- -------------------------- --------------------------- ---------------------------
  Intima--media thickness                                                                                                         
  \<1.0 mm                  877    20      8140.94        2.46             1.00                       1.00                        1.00
  1.0--2.0 mm               1533   107     14,714.21      7.27             1.58 (0.97, 2.57)          1.53 (0.94, 2.49)           1.53 (0.94, 2.50)
  ≥2.0 mm                   546    115     4955.72        23.21            2.22 (1.34, 3.68) \*\*     2.06 (1.24, 3.42) \*\*      1.79 (1.07, 3.00) \*
  *p* for trend                                                            \<0.001                    0.002                       0.003
  Carotid plaque                                                                                                                  
  No                        1517   47      14,453.17      3.25             1.00                       1.00                        1.00
  Yes                       1439   195     13,357.71      14.60            1.89 (1.35, 2.64) \*\*\*   1.82 (1.30, 2.55) \*\*\*    1.65 (1.17, 2.32) \*\*
  Carotid stenosis                                                                                                                
  \<25%                     2525   140     24,074.52      5.82             1.00                       1.00                        1.00
  25%--36%                  246    51      2118.61        24.07            1.75 (1.25, 2.46) \*\*     1.71 (1.22, 2.39) \*\*      1.57 (1.12, 2.22) \*\*
  ≥36%                      185    51      1617.74        31.53            1.54 (1.09, 2.18) \*       1.49 (1.05, 2.10) \*        1.15 (0.80, 1.67)
  *p* for trend                                                            0.004                      0.007                       0.22

\* *p* \< 0.05; \*\* *p* \< 0.01; \*\*\* *p* \< 0.001. ^1^ Multivariate adjustment for age, sex, education, marital status, BMI, smoking, alcohol drinking, and physical activity. ^2^ Multivariate adjustment for age, sex, education, marital status, BMI, smoking, alcohol drinking, physical activity, hypertension, diabetes mellitus, heart disease, stroke, cancer, chronic kidney disease, fasting plasma glucose, total cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, WBC, ACR, fasting insulin, and hs-CRP. Incidence rate = number of incident cases/person-years \* 1000; HR: hazard ratio; CI: confidence interval.

[^1]: Equal contribution as the first author.
